加载中
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
前收盘价
US$1.36
−US$0.07 · -4.90%
盘后
US$1.42
+US$0.06 · +4.41%
10月12日 18:46 ET
盘中时间采用ET。市场数据可能有所延迟。
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
日内区间
当前US$1.36
52周区间
当前US$1.36
盘中时间采用ET。市场数据可能有所延迟。
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
日内区间
当前US$1.36
52周区间
当前US$1.36
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 4092.8万 USD | 3255.12万 USD | 1924.12万 USD | 1555.52万 USD | 1385.64万 USD |
| 销货成本 | 1403.97万 USD | 936.59万 USD | 605.88万 USD | 530.21万 USD | 354.41万 USD |
| 毛利 | 2688.83万 USD | 2318.53万 USD | 1318.24万 USD | 1025.31万 USD | 1031.23万 USD |
| 研究与开发 | 694.38万 USD | 477.2万 USD | 263.65万 USD | 248.25万 USD | 255.74万 USD |
| 销售、一般及管理费用 | 3434.63万 USD | 2462万 USD | 1877.74万 USD | 1844.28万 USD | 1802.3万 USD |
| 营业费用 | 4129.02万 USD | 2939.2万 USD | 2141.39万 USD | 2092.53万 USD | 2058.03万 USD |
| 利息收入 | 47.7万 USD | 38.86万 USD | 41.03万 USD | 8.87万 USD | 1612 USD |
| 利息支出 | 92.78万 USD | — | — | — | — |
| 折旧和摊销 | 197.97万 USD | 77.7万 USD | 51.77万 USD | 54.26万 USD | 33.6万 USD |
| 营业利润 | −1440.18万 USD | −620.67万 USD | −823.15万 USD | −1067.22万 USD | −1026.81万 USD |
| 净利润 | −1557.39万 USD | −618.37万 USD | −814.76万 USD | −1072.1万 USD | −1037.23万 USD |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2020年1月31日 | 1:30 | — | — |
已生效 2020年1月31日
1:30
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
